» Articles » PMID: 17178402

Essential Roles for GSK-3s and GSK-3-primed Substrates in Neurotrophin-induced and Hippocampal Axon Growth

Overview
Journal Neuron
Publisher Cell Press
Specialty Neurology
Date 2006 Dec 21
PMID 17178402
Citations 127
Authors
Affiliations
Soon will be listed here.
Abstract

Glycogen synthase kinase-3beta (GSK-3beta) is thought to mediate morphological responses to a variety of extracellular signals. Surprisingly, we found no gross morphological deficits in nervous system development in GSK-3beta null mice. We therefore designed an shRNA that targeted both GSK-3 isoforms. Strong knockdown of both GSK-3alpha and beta markedly reduced axon growth in dissociated cultures and slice preparations. We then assessed the role of different GSK-3 substrates in regulating axon morphology. Elimination of activity toward primed substrates only using the GSK-3 R96A mutant was associated with a defect in axon polarity (axon branching) compared to an overall reduction in axon growth induced by a kinase-dead mutant. Consistent with this finding, moderate reduction of GSK-3 activity by pharmacological inhibitors induced axon branching and was associated primarily with effects on primed substrates. Our results suggest that GSK-3 is a downstream convergent point for many axon growth regulatory pathways and that differential regulation of primed versus all GSK-3 substrates is associated with a specific morphological outcome.

Citing Articles

Glycogen synthase kinase 3 (GSK3) inhibition: a potential therapeutic strategy for Alzheimer's disease.

Karati D, Meur S, Roy S, Mukherjee S, Debnath B, Jha S Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39432068 DOI: 10.1007/s00210-024-03500-1.


GSK3: A potential target and pending issues for treatment of Alzheimer's disease.

Zhao J, Wei M, Guo M, Wang M, Niu H, Xu T CNS Neurosci Ther. 2024; 30(7):e14818.

PMID: 38946682 PMC: 11215492. DOI: 10.1111/cns.14818.


Microtubule-binding protein MAP1B regulates interstitial axon branching of cortical neurons via the tubulin tyrosination cycle.

Ziak J, Dorskind J, Trigg B, Sudarsanam S, Jin X, Hand R EMBO J. 2024; 43(7):1214-1243.

PMID: 38388748 PMC: 10987652. DOI: 10.1038/s44318-024-00050-3.


Integrin-mediated electric axon guidance underlying optic nerve formation in the embryonic chick retina.

Yamashita M Commun Biol. 2023; 6(1):680.

PMID: 37391492 PMC: 10313674. DOI: 10.1038/s42003-023-05056-x.


Focal adhesion is associated with lithium response in bipolar disorder: evidence from a network-based multi-omics analysis.

Niemsiri V, Rosenthal S, Nievergelt C, Maihofer A, Marchetto M, Santos R Mol Psychiatry. 2023; 29(1):6-19.

PMID: 36991131 PMC: 11078741. DOI: 10.1038/s41380-022-01909-9.


References
1.
He X, Woodgett J, Varmus H, Dawid I . Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos. Nature. 1995; 374(6523):617-22. DOI: 10.1038/374617a0. View

2.
Doble B, Woodgett J . GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci. 2003; 116(Pt 7):1175-86. PMC: 3006448. DOI: 10.1242/jcs.00384. View

3.
Ali A, Hoeflich K, Woodgett J . Glycogen synthase kinase-3: properties, functions, and regulation. Chem Rev. 2001; 101(8):2527-40. DOI: 10.1021/cr000110o. View

4.
Meijer L, Skaltsounis A, Magiatis P, Polychronopoulos P, Knockaert M, Leost M . GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem Biol. 2004; 10(12):1255-66. DOI: 10.1016/j.chembiol.2003.11.010. View

5.
Eng S, Gratwick K, Rhee J, Fedtsova N, Gan L, Turner E . Defects in sensory axon growth precede neuronal death in Brn3a-deficient mice. J Neurosci. 2001; 21(2):541-9. PMC: 6763803. View